Single-Agent Immunotherapy for Two Types of Cancer in One Patient

Ann Intern Med. 2019 Feb 5;170(3):210-211. doi: 10.7326/L18-0360. Epub 2018 Sep 25.

Authors

Benjamin Musher¹, Ahmad Rahal¹

Affiliation

¹ Baylor College of Medicine, Houston, Texas (B.M., A.R.).

PMID: 30264147
DOI: 10.7326/L18-0360

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / drug therapy*
Adenocarcinoma / genetics
Antibodies, Monoclonal, Humanized / therapeutic use*
Antineoplastic Agents, Immunological / therapeutic use*
Cholangiocarcinoma / drug therapy*
Cholangiocarcinoma / genetics
Colonic Neoplasms / drug therapy*
Colonic Neoplasms / genetics
Colorectal Neoplasms, Hereditary Nonpolyposis / complications
Colorectal Neoplasms, Hereditary Nonpolyposis / genetics
DNA Mismatch Repair
Female
Humans
Liver Neoplasms / drug therapy*
Liver Neoplasms / genetics
Middle Aged
Neoplasms, Multiple Primary / drug therapy*
Neoplasms, Multiple Primary / genetics

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
pembrolizumab